Evidence map›Paper›PMID 38535253›Full record

ReviewJournal of functional biomaterials2024

Three-Dimensional Printing Methods for Bioceramic-Based Scaffold Fabrication for Craniomaxillofacial Bone Tissue Engineering.

Zeeshan Sheikh, Vasudev Vivekanand Nayak, Umer Daood, Anupreet Kaur, Hanan Moussa, Abbas Canteenwala, Pierre-Luc Michaud, Ísis de Fátima Balderrama, Edisa de Oliveira Sousa, Nick Tovar and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of functional biomaterials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 4 countries.

Zeeshan SheikhDepartment of Applied Oral Sciences, Faculty of Dentistry, Dalhousie University, 5981 University Avenue, Halifax, NS B3H 1W2, Canada.ORCID 0000-0001-5942-9985
Vasudev Vivekanand NayakDepartment of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Umer DaoodSchool of Dentistry, International Medical University, Jln Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur 57000, Malaysia.
Anupreet KaurFaculty of Health Sciences, Schulich School of Medicine and Dentistry, University of Western Ontario, 1151 Richmond St., London, ON N6A 5C1, Canada.
Hanan MoussaDepartment of Applied Oral Sciences, Faculty of Dentistry, Dalhousie University, 5981 University Avenue, Halifax, NS B3H 1W2, Canada.
Abbas CanteenwalaSchulich School of Medicine and Dentistry, Western University, 1151 Richmond St, London, ON N6A 5C1, Canada.ORCID 0000-0002-1242-2396
Pierre-Luc MichaudDepartment of Dental Clinical Sciences, Faculty of Dentistry, Dalhousie University, 5981 University Avenue, Halifax, NS B3H 1W2, Canada.ORCID 0000-0001-6511-4146
Ísis de Fátima BalderramaBiomaterials Division, NYU Dentistry, New York, NY 10010, USA.
Edisa de Oliveira SousaBiomaterials Division, NYU Dentistry, New York, NY 10010, USA.
Nick TovarDepartment of Oral and Maxillofacial Surgery, NYU Dentistry, New York, NY 10010, USA.
Andrea TorroniHansjörg Wyss Department of Plastic Surgery, NYU Grossman School of Medicine, New York, NY 10016, USA.
Michael GlogauerDepartment of Dental Oncology, University Health Network, Princess Margaret Cancer Hospital, 610 University Avenue, Toronto, ON M5G 2M9, Canada.ORCID 0000-0002-6248-5977
Huzefa TalibDepartment of Oral and Maxillofacial Surgery, NYU Dentistry, New York, NY 10010, USA.
Paulo G CoelhoDepartment of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Lukasz WitekBiomaterials Division, NYU Dentistry, New York, NY 10010, USA.ORCID 0000-0003-1458-6527
New York University · USDalhousie University · CAUniversity of Miami · USWestern University · CAIMU University · MYUniversidade de São Paulo · BRUniversidade Estadual Paulista (Unesp) · BRUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three-dimensional printing (3DP) technology has revolutionized the field of the use of bioceramics for maxillofacial and periodontal applications, offering unprecedented control over the shape, size, and structure of bioceramic implants. In addition, bioceramics have become attractive materials for these applications due to their biocompatibility, biostability, and favorable mechanical properties. However, despite their advantages, bioceramic implants are still associated with inferior biological performance issues after implantation, such as slow osseointegration, inadequate tissue response, and an increased risk of implant failure. To address these challenges, researchers have been developing strategies to improve the biological performance of 3D-printed bioceramic implants. The purpose of this review is to provide an overview of 3DP techniques and strategies for bioceramic materials designed for bone regeneration. The review also addresses the use and incorporation of active biomolecules in 3D-printed bioceramic constructs to stimulate bone regeneration. By controlling the surface roughness and chemical composition of the implant, the construct can be tailored to promote osseointegration and reduce the risk of adverse tissue reactions. Additionally, growth factors, such as bone morphogenic proteins (rhBMP-2) and pharmacologic agent (dipyridamole), can be incorporated to promote the growth of new bone tissue. Incorporating porosity into bioceramic constructs can improve bone tissue formation and the overall biological response of the implant. As such, employing surface modification, combining with other materials, and incorporating the 3DP workflow can lead to better patient healing outcomes.

Indexed as

3D-printingbioceramicsbone tissue engineeringscaffold fabrication

Identifiers

PMID38535253
PMCPMC10970952
OpenAlexW4392357719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.